EssilorLuxottica Société anonyme against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-09-23T15:36:14+00:00 UTC · updates daily
MRNA leads 4 of the 5 windows we measure — over 1 month EL.PA is -7.3% and MRNA +31.1%; over year to date EL.PA is -44.4% and MRNA +517.5%.
| EL.PA | MRNA | |
|---|---|---|
| Price | $149.95 | $182.11 |
| 1 day | +3.8%lead | -0.2% |
| 5 days | +3.3% | +25.1%lead |
| 1 month | -7.3% | +31.1%lead |
| 6 months | -22.3% | +255.1%lead |
| Year to date | -44.4% | +517.5%lead |
| 52-week position | 6% of range | 94% of range |
| 52-week range | $138.30–$323.80 | $22.28–$192.31 |
| vs 50-day average | below $159.21 | above $104.86 |
| vs 200-day average | below $199.87 | above $62.57 |
| RSI (14) | 45 | 70 |
| Next earnings | 2026-02-11 | 2026-11-05 |
EL.PA trades at $149.95, below its 50-day average of $159.21, and below the 200-day at $199.87. It sits at 6% of its 52-week range ($138.30–$323.80); 14-day RSI is 45, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $150.00 (0.0% away) and the first support below is $139.00 (7.3% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
MRNA trades at $182.11, above its 50-day average of $104.86, and above the 200-day at $62.57. It sits at 94% of its 52-week range ($22.28–$192.31); 14-day RSI is 70, in overbought territory; an average session moves it about 6.3%. For levels, the first level overhead is $182.56 (0.2% away) and the first support below is $175.00 (3.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 6.3% against 2.6% for EL.PA, so an identical position size carries roughly 2.4× the daily risk.
The comparison turns on those levels: EL.PA clearing $150.00 or losing $139.00; MRNA clearing $182.56 or losing $175.00. Until one of them gives way, the relative reading above stands.